VIVASURE MEDICAL ANNOUNCES ACQUISITION BY HAEMONETICS CORPORATION
VIVASURE : DEAL FOR TRANSACTION VALUED UP TO EUR 185M (ABOUT $215M) ON COMPLETION OF CERTAIN MILESTONES
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.